Piramal Enterprises has sold its entire direct investment of 20% of the fully paid-up equity share capital in Shriram Investment Holdings on March 26, 2024. This transaction is aligned with its focus on monetizing non-core assets. The proceeds from the transaction will further strengthen company’s balance sheet.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.